,X,Filing Date,Trade Date,Ticker,Insider Name,Title,Trade Type,Price,Qty,Owned,ΔOwn,Value,1d,1w,1m,6m,ticker
0,D,2021-08-04 16:09:57,2021-08-02,FLXN,Andrews William T.,Chief Medical Officer,A - Grant,$0.00,34250,34250,New,+$0,,,,,FLXN
1,,2021-07-20 20:51:52,2021-07-19,FLXN,Willwerth Christina,Chief Strategy Officer,S - Sale,$6.45,-3945,141241,-3%,"-$25,445",,,,,FLXN
2,,2021-07-20 20:49:54,2021-07-19,FLXN,Wentworth Kerry,Chief Regulatory Officer,S - Sale,$6.45,-3944,146362,-3%,"-$25,439",,,,,FLXN
3,,2021-07-20 20:48:00,2021-07-19,FLXN,Muzikant Adam,Chief Business Officer,S - Sale,$6.45,-1870,103666,-2%,"-$12,062",,,,,FLXN
4,,2021-07-20 20:45:42,2021-07-19,FLXN,Levine Mark S.,GC,S - Sale,$6.45,-3945,133486,-3%,"-$25,445",,,,,FLXN
5,,2021-07-20 20:44:14,2021-07-19,FLXN,Clayman Michael D.,"Pres, CEO",F - Tax,$0.00,-13859,1122033,-1%,-$0,,,,,FLXN
6,D,2021-06-28 18:42:16,2021-06-24,FLXN,Kwo Elizabeth,Dir,A - Grant,$0.00,4500,4500,New,+$0,,,,,FLXN
7,D,2021-06-28 18:40:21,2021-06-24,FLXN,Merrifield C Ann,Dir,A - Grant,$0.00,4500,19000,+31%,+$0,,,,,FLXN
8,D,2021-06-28 18:38:11,2021-06-24,FLXN,Canute Scott A,Dir,A - Grant,$0.00,4500,9000,+100%,+$0,,,,,FLXN
9,D,2021-06-28 18:32:52,2021-06-24,FLXN,Colella Samuel D,Dir,A - Grant,$0.00,4500,1496564,0%,+$0,,,,,FLXN
10,D,2021-06-28 18:30:40,2021-06-24,FLXN,Stejbach Mark,Dir,A - Grant,$0.00,4500,12631,+55%,+$0,,,,,FLXN
11,D,2021-06-28 18:25:55,2021-06-24,FLXN,Lukatch Heath,Dir,A - Grant,$0.00,4500,9000,+100%,+$0,,,,,FLXN
12,D,2021-06-28 18:24:05,2021-06-24,FLXN,Mahaffy Patrick J,Dir,A - Grant,$0.00,4500,39824,+13%,+$0,,,,,FLXN
13,D,2021-06-28 18:16:42,2021-06-24,FLXN,Milinazzo Alan,Dir,A - Grant,$0.00,4500,27450,+20%,+$0,,,,,FLXN
14,,2021-06-28 18:13:33,2021-06-21,FLXN,Muzikant Adam,Chief Business Officer,A - Grant,$7.78,2081,105536,+2%,"+$16,190",,,,,FLXN
15,,2021-06-28 18:09:25,2021-06-21,FLXN,Wentworth Kerry,Chief Regulatory Officer,A - Grant,$7.78,539,150306,0%,"+$4,193",,,,,FLXN
16,,2021-06-28 18:04:37,2021-06-21,FLXN,Clayman Michael D.,"Pres, CEO",A - Grant,$7.78,1700,1135892,0%,"+$13,226",,,,,FLXN
17,D,2021-06-03 16:20:29,2021-06-01,FLXN,Driscoll Frederick W,CFO,A - Grant,$0.00,28000,30680,>999%,+$0,,,,,FLXN
18,,2021-05-12 17:06:20,2021-05-10,FLXN,Arkowitz David,CFO,S - Sale,$7.23,-2229,220719,-1%,"-$16,116",,,,,FLXN
19,M,2021-03-23 19:01:30,2021-01-08,FLXN,Clayman Michael D.,"Pres, CEO",G - Gift,$0.00,-25861,1134192,-2%,-$0,,,,,FLXN
20,,2021-03-16 17:11:40,2021-03-15,FLXN,Layman Melissa,Chief Commercial Officer,S - Sale,$11.80,-4520,103956,-4%,"-$53,336",,,,,FLXN
21,D,2021-03-03 18:42:48,2021-03-01,FLXN,Muzikant Adam,Chief Business Officer,A - Grant,$0.00,30000,103455,+41%,+$0,,,,,FLXN
22,D,2021-03-03 18:35:50,2021-03-01,FLXN,Wentworth Kerry,Chief Regulatory Officer,A - Grant,$0.00,30000,149767,+25%,+$0,,,,,FLXN
23,D,2021-03-03 18:33:28,2021-03-01,FLXN,Willwerth Christina,Chief Strategy Officer,A - Grant,$0.00,30000,145186,+26%,+$0,,,,,FLXN
24,D,2021-03-03 18:31:34,2021-03-01,FLXN,Levine Mark S.,GC,A - Grant,$0.00,30000,137431,+28%,+$0,,,,,FLXN
25,D,2021-03-03 18:29:22,2021-03-01,FLXN,Kelley Scott,Chief Medical Officer,A - Grant,$0.00,30000,143549,+26%,+$0,,,,,FLXN
26,D,2021-03-03 18:26:11,2021-03-01,FLXN,Arkowitz David,CFO,A - Grant,$0.00,71900,222948,+48%,+$0,,,,,FLXN
27,D,2021-03-03 18:22:46,2021-03-01,FLXN,Layman Melissa,Chief Commercial Officer,A - Grant,$0.00,20100,108476,+23%,+$0,,,,,FLXN
28,D,2021-03-03 18:16:38,2021-03-01,FLXN,Clayman Michael D.,"Pres, CEO",A - Grant,$0.00,106100,1134192,+10%,+$0,,,,,FLXN
29,,2021-01-29 20:19:13,2021-01-27,FLXN,Layman Melissa,Chief Commercial Officer,A - Grant,$0.00,30000,88376,+51%,+$0,,,,,FLXN
30,,2021-01-29 20:19:13,2021-01-28,FLXN,Layman Melissa,Chief Commercial Officer,S - Sale,$12.55,-2624,88376,-3%,"-$32,931",,,,,FLXN
31,,2021-01-29 20:17:11,2021-01-27,FLXN,Clayman Michael D.,"Pres, CEO",A - Grant,$0.00,119500,1028092,+13%,+$0,,,,,FLXN
32,,2021-01-29 20:17:11,2021-01-28,FLXN,Clayman Michael D.,"Pres, CEO",F - Tax,$12.37,-8776,1028092,-1%,"-$108,559",,,,,FLXN
33,,2021-01-07 18:02:27,2021-01-05,FLXN,Muzikant Adam,Chief Business Officer,S - Sale,$11.13,-4005,73455,-5%,"-$44,576",,,,,FLXN
34,,2021-01-07 17:58:33,2021-01-05,FLXN,Kelley Scott,Chief Medical Officer,S - Sale,$11.13,-6829,113549,-6%,"-$76,007",,,,,FLXN
35,,2021-01-07 17:56:57,2021-01-05,FLXN,Wentworth Kerry,Chief Regulatory Officer,S - Sale,$11.13,-6829,119767,-5%,"-$76,007",,,,,FLXN
36,,2021-01-07 17:55:19,2021-01-05,FLXN,Willwerth Christina,Chief Strategy Officer,S - Sale,$11.13,-6602,115186,-5%,"-$73,480",,,,,FLXN
37,,2021-01-07 17:52:47,2021-01-05,FLXN,Levine Mark S.,GC,S - Sale,$11.13,-6829,107431,-6%,"-$76,007",,,,,FLXN
38,,2021-01-07 17:50:04,2021-01-05,FLXN,Arkowitz David,CFO,S - Sale,$11.13,-6073,151048,-4%,"-$67,592",,,,,FLXN
39,,2021-01-07 17:47:08,2021-01-05,FLXN,Clayman Michael D.,"Pres, CEO",F - Tax,$0.00,-2530,917368,0%,-$0,,,,,FLXN
40,,2021-01-07 17:47:08,2020-07-08,FLXN,Clayman Michael D.,"Pres, CEO",G - Gift,$0.00,-1303,917368,0%,-$0,,,,,FLXN
41,,2020-07-20 21:33:14,2020-07-16,FLXN,Arkowitz David,CFO,A - Grant,$0.00,38750,157121,+33%,+$0,,,,,FLXN
42,,2020-07-20 21:31:21,2020-07-16,FLXN,Kelley Scott,Chief Medical Officer,A - Grant,$0.00,38750,119710,+48%,+$0,,,,,FLXN
43,,2020-07-20 21:28:41,2020-07-16,FLXN,Willwerth Christina,Chief Strategy Officer,A - Grant,$0.00,38750,121788,+47%,+$0,,,,,FLXN
44,,2020-07-20 21:26:56,2020-07-16,FLXN,Clayman Michael D.,"Pres, CEO",A - Grant,$0.00,93750,919898,+11%,+$0,,,,,FLXN
45,,2020-07-20 21:24:58,2020-07-16,FLXN,Levine Mark S.,GC,A - Grant,$0.00,38750,114260,+51%,+$0,,,,,FLXN
46,,2020-07-20 21:23:08,2020-07-16,FLXN,Wentworth Kerry,Chief Regulatory Officer,A - Grant,$0.00,38750,126180,+44%,+$0,,,,,FLXN
47,D,2020-07-10 16:06:07,2020-07-09,FLXN,Milinazzo Alan,Dir,M - OptEx,$2.20,18450,22950,+410%,"+$40,500",,,,,FLXN
48,,2020-06-24 16:21:37,2020-06-22,FLXN,Arkowitz David,CFO,A - Grant,$10.83,1303,118371,+1%,"+$14,111",,,,,FLXN
49,,2020-06-24 16:18:53,2020-06-22,FLXN,Clayman Michael D.,"Pres, CEO",A - Grant,$10.83,1303,826148,0%,"+$14,111",,,,,FLXN
50,,2020-06-24 16:15:33,2020-06-22,FLXN,Kelley Scott,Chief Medical Officer,A - Grant,$10.83,595,80960,+1%,"+$6,444",,,,,FLXN
51,,2020-06-24 16:12:40,2020-06-22,FLXN,Levine Mark S.,GC,A - Grant,$10.83,1023,75510,+1%,"+$11,079",,,,,FLXN
52,,2020-06-24 16:09:34,2020-06-22,FLXN,Wentworth Kerry,Chief Regulatory Officer,A - Grant,$10.83,369,87430,0%,"+$3,996",,,,,FLXN
53,D,2020-06-12 16:25:45,2020-06-10,FLXN,Stejbach Mark,Dir,A - Grant,$0.00,4500,8131,+124%,+$0,,,,,FLXN
54,D,2020-06-12 16:24:24,2020-06-10,FLXN,Mahaffy Patrick J,Dir,A - Grant,$0.00,4500,35324,+15%,+$0,,,,,FLXN
55,D,2020-06-12 16:21:07,2020-06-10,FLXN,Milinazzo Alan,Dir,A - Grant,$0.00,4500,4500,New,+$0,,,,,FLXN
56,D,2020-06-12 16:19:38,2020-06-10,FLXN,Merrifield C Ann,Dir,A - Grant,$0.00,4500,14500,+45%,+$0,,,,,FLXN
57,D,2020-06-12 16:17:55,2020-06-10,FLXN,Mahatme Sandesh,Dir,A - Grant,$0.00,4500,4500,New,+$0,,,,,FLXN
58,D,2020-06-12 16:15:51,2020-06-10,FLXN,Lukatch Heath,Dir,A - Grant,$0.00,4500,4500,New,+$0,,,,,FLXN
59,D,2020-06-12 16:13:56,2020-06-10,FLXN,Colella Samuel D,"Dir, 10%",A - Grant,$0.00,4500,4001429,0%,+$0,,,,,FLXN
60,D,2020-06-12 16:11:35,2020-06-10,FLXN,Canute Scott A,Dir,A - Grant,$0.00,4500,4500,New,+$0,,,,,FLXN
61,,2020-05-27 16:14:20,2020-05-26,FLXN,Stejbach Mark,Dir,P - Purchase,$9.75,2051,3631,+130%,"+$19,997",,,,,FLXN
62,,2020-05-27 16:11:48,2020-05-26,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$9.75,10256,824845,+1%,"+$99,996",,,,,FLXN
63,,2020-05-11 16:11:08,2020-05-07,FLXN,Arkowitz David,CFO,S - Sale,$10.88,-2413,117068,-2%,"-$26,253",,,,,FLXN
64,D,2020-04-03 16:11:21,2020-04-01,FLXN,Layman Melissa,Chief Commercial Officer,A - Grant,$0.00,61000,61000,New,+$0,,,,,FLXN
65,D,2020-03-03 16:21:31,2020-03-02,FLXN,Willwerth Christina,Chief Strategy Officer,A - Grant,$0.00,31000,83473,+59%,+$0,,,,,FLXN
66,D,2020-03-03 16:18:11,2020-03-02,FLXN,Wentworth Kerry,Chief Regulatory Officer,A - Grant,$0.00,31000,87061,+55%,+$0,,,,,FLXN
67,D,2020-03-03 16:16:13,2020-03-02,FLXN,Levine Mark S.,GC,A - Grant,$0.00,31000,74487,+71%,+$0,,,,,FLXN
68,D,2020-03-03 16:14:39,2020-03-02,FLXN,Arkowitz David,CFO,A - Grant,$0.00,31000,119481,+35%,+$0,,,,,FLXN
69,D,2020-03-03 16:11:53,2020-03-02,FLXN,Kelley Scott,Chief Medical Officer,A - Grant,$0.00,31000,80365,+63%,+$0,,,,,FLXN
70,,2020-01-07 17:40:06,2020-01-03,FLXN,Clayman Michael D.,"Pres, CEO",F - Tax,$0.00,-2494,814589,0%,-$0,,,,,FLXN
71,M,2020-01-07 17:40:06,2019-10-09,FLXN,Clayman Michael D.,"Pres, CEO",G - Gift,$0.00,-31710,814589,-4%,-$0,,,,,FLXN
72,,2020-01-07 16:39:05,2020-01-03,FLXN,Willwerth Christina,Chief Strategy Officer,S - Sale,$0.00,-3533,52473,-6%,-$0,,,,,FLXN
73,,2020-01-07 16:37:58,2020-01-03,FLXN,Kelley Scott,Chief Medical Officer,S - Sale,$0.00,-3724,49365,-7%,-$0,,,,,FLXN
74,,2020-01-07 16:35:41,2020-01-03,FLXN,Levine Mark S.,GC,S - Sale,$0.00,-3724,43487,-8%,-$0,,,,,FLXN
75,,2020-01-07 16:33:06,2020-01-03,FLXN,Wentworth Kerry,Chief Regulatory Officer,S - Sale,$0.00,-3724,56061,-6%,-$0,,,,,FLXN
76,,2020-01-07 16:31:01,2020-01-03,FLXN,Arkowitz David,CFO,S - Sale,$0.00,-3095,88481,-3%,-$0,,,,,FLXN
77,,2020-01-07 16:28:24,2020-01-03,FLXN,Bodick Neil,Chief Scientific Officer,S - Sale,$0.00,-3851,489836,-1%,-$0,,,,,FLXN
78,,2019-10-08 16:29:16,2019-10-07,FLXN,Willwerth Christina,Chief Strategy Officer,F - Tax,$13.98,-1002,66167,-1%,"-$14,008",,,,,FLXN
79,D,2019-10-08 16:27:35,2019-10-07,FLXN,Wentworth Kerry,Chief Regulatory Officer,F - Tax,$13.98,-1002,59394,-2%,"-$14,008",,,,,FLXN
80,D,2019-10-08 16:27:35,2019-10-06,FLXN,Wentworth Kerry,Chief Regulatory Officer,M - OptEx,$0.00,3400,59394,+6%,+$0,,,,,FLXN
81,D,2019-10-08 16:25:20,2019-10-07,FLXN,Clayman Michael D.,"Pres, CEO",F - Tax,$13.98,-4402,816424,-1%,"-$61,540",,,,,FLXN
82,D,2019-10-08 16:25:20,2019-10-06,FLXN,Clayman Michael D.,"Pres, CEO",M - OptEx,$0.00,14800,816424,+2%,+$0,,,,,FLXN
83,,2019-10-08 16:21:57,2019-10-07,FLXN,Kelley Scott,Chief Medical Officer,F - Tax,$13.98,-334,53089,-1%,"-$4,669",,,,,FLXN
84,D,2019-10-08 16:19:15,2019-10-07,FLXN,Bodick Neil,Chief Scientific Officer,F - Tax,$13.98,-1346,493687,0%,"-$18,817",,,,,FLXN
85,D,2019-10-08 16:19:15,2019-10-06,FLXN,Bodick Neil,Chief Scientific Officer,M - OptEx,$0.00,4568,493687,+1%,+$0,,,,,FLXN
86,D,2019-08-29 16:46:03,2019-08-29,FLXN,Mahaffy Patrick J,Dir,M - OptEx,$0.16,30824,30824,New,"+$4,932",,,,,FLXN
87,D,2019-08-14 16:06:59,2019-08-13,FLXN,Willwerth Christina,Chief Strategy Officer,M - OptEx,$0.16,8750,67169,+15%,"+$1,400",,,,,FLXN
88,,2019-08-09 16:05:41,2019-08-08,FLXN,Colella Samuel D,"Dir, 10%",P - Purchase,$10.74,2000,3996929,0%,"+$21,480",,,,,FLXN
89,,2019-08-08 16:38:12,2019-08-08,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$10.85,2317,806026,0%,"+$25,136",,,,,FLXN
90,,2019-06-24 17:23:26,2019-06-21,FLXN,Clayman Michael D.,"Pres, CEO",A - Grant,$9.81,1492,803709,0%,"+$14,637",,,,,FLXN
91,M,2019-06-24 17:23:26,2019-01-28,FLXN,Clayman Michael D.,"Pres, CEO",G - Gift,$0.00,-12856,803709,+2%,-$0,,,,,FLXN
92,,2019-06-24 16:14:45,2019-06-21,FLXN,Levine Mark S.,GC,A - Grant,$9.81,1213,46273,+3%,"+$11,900",,,,,FLXN
93,,2019-06-24 16:13:12,2019-06-21,FLXN,Wentworth Kerry,Chief Regulatory Officer,A - Grant,$9.81,389,56996,+1%,"+$3,816",,,,,FLXN
94,,2019-06-24 16:11:36,2019-06-21,FLXN,Kelley Scott,Chief Medical Officer,A - Grant,$9.81,2152,53423,+4%,"+$21,111",,,,,FLXN
95,,2019-06-24 16:10:17,2019-06-21,FLXN,Arkowitz David,CFO,A - Grant,$9.81,2152,91576,+2%,"+$21,111",,,,,FLXN
96,,2019-06-03 16:18:03,2019-05-31,FLXN,Arkowitz David,CFO,P - Purchase,$11.05,2500,89424,+3%,"+$27,627",,,,,FLXN
97,,2019-05-24 09:15:23,2019-05-23,FLXN,Merrifield C Ann,Dir,P - Purchase,$12.64,8000,10000,+400%,"+$101,120",,,,,FLXN
98,,2019-05-15 16:05:29,2019-05-13,FLXN,Arkowitz David,CFO,P - Purchase,$11.99,4000,86924,+5%,"+$47,960",,,,,FLXN
99,,2019-05-13 09:15:40,2019-05-10,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$12.48,4012,802217,+1%,"+$50,067",,,,,FLXN
100,,2019-05-09 16:32:58,2019-05-08,FLXN,Arkowitz David,CFO,S - Sale,$10.06,-2248,82924,-3%,"-$22,615",,,,,FLXN
101,,2019-03-13 16:11:48,2019-03-12,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$12.36,4046,798205,+1%,"+$50,009",,,,,FLXN
102,AD,2019-03-05 20:17:20,2018-10-08,FLXN,Wentworth Kerry,Chief Regulatory Officer,F - Tax,$18.60,-1002,20876,-5%,"-$18,637",,,,,FLXN
103,AD,2019-03-05 20:17:20,2018-10-06,FLXN,Wentworth Kerry,Chief Regulatory Officer,M - OptEx,$0.00,3400,20876,+19%,+$0,,,,,FLXN
104,D,2019-03-05 18:18:09,2019-03-01,FLXN,Wentworth Kerry,Chief Regulatory Officer,A - Grant,$0.00,36000,56607,+175%,+$0,,,,,FLXN
105,D,2019-03-05 17:32:19,2019-03-01,FLXN,Kelley Scott,Chief Medical Officer,A - Grant,$0.00,36000,51271,+236%,+$0,,,,,FLXN
106,D,2019-03-05 16:30:46,2019-03-01,FLXN,Willwerth Christina,Chief Strategy Officer,A - Grant,$0.00,36000,58419,+161%,+$0,,,,,FLXN
107,D,2019-03-05 16:29:29,2019-03-01,FLXN,Levine Mark S.,GC,A - Grant,$0.00,36000,45060,+397%,+$0,,,,,FLXN
108,D,2019-03-05 16:27:56,2019-03-01,FLXN,Arkowitz David,CFO,A - Grant,$0.00,36000,85172,+73%,+$0,,,,,FLXN
109,D,2019-03-05 16:26:23,2019-03-01,FLXN,Bodick Neil,Chief Scientific Officer,A - Grant,$0.00,36000,490465,+8%,+$0,,,,,FLXN
110,,2019-01-04 17:12:25,2019-01-03,FLXN,Levine Mark S.,GC,S - Sale,$12.36,-734,9060,-7%,"-$9,072",,,,,FLXN
111,,2019-01-04 17:10:53,2019-01-03,FLXN,Wentworth Kerry,Chief Regulatory Officer,S - Sale,$12.36,-622,17207,-3%,"-$7,688",,,,,FLXN
112,,2019-01-04 17:09:22,2019-01-03,FLXN,Kelley Scott,Chief Medical Officer,S - Sale,$12.36,-622,15271,-4%,"-$7,688",,,,,FLXN
113,,2019-01-04 17:06:16,2019-01-03,FLXN,Bodick Neil,Chief Scientific Officer,S - Sale,$12.36,-746,454465,0%,"-$9,221",,,,,FLXN
114,,2019-01-04 17:03:59,2019-01-03,FLXN,Clayman Michael D.,"Pres, CEO",S - Sale,$12.36,-3278,794159,0%,"-$40,516",,,,,FLXN
115,M,2018-11-13 09:17:53,2018-06-27,FLXN,Clayman Michael D.,"Pres, CEO",G - Gift,$0.00,-39366,796515,+5%,-$0,,,,,FLXN
116,,2018-11-13 09:17:53,2018-11-09,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$17.10,5000,796515,+1%,"+$85,477",,,,,FLXN
117,,2018-11-13 09:14:51,2018-11-09,FLXN,Arkowitz David,CFO,P - Purchase,$16.56,4000,48250,+9%,"+$66,222",,,,,FLXN
118,D,2018-10-09 17:08:42,2018-10-08,FLXN,Bodick Neil,Chief Scientific Officer,F - Tax,$18.60,-1345,455211,0%,"-$25,017",,,,,FLXN
119,D,2018-10-09 17:08:42,2018-10-08,FLXN,Bodick Neil,Chief Scientific Officer,M - OptEx,$0.00,4566,455211,+1%,+$0,,,,,FLXN
120,D,2018-10-09 16:31:50,2018-10-08,FLXN,Clayman Michael D.,"Pres, CEO",F - Tax,$18.60,-6233,791515,-1%,"-$115,934",,,,,FLXN
121,D,2018-10-09 16:31:50,2018-10-08,FLXN,Clayman Michael D.,"Pres, CEO",M - OptEx,$0.00,14800,791515,+2%,+$0,,,,,FLXN
122,,2018-10-09 16:30:50,2018-10-08,FLXN,Wentworth Kerry,Chief Regulatory Officer,F - Tax,$18.60,-1002,17476,-5%,"-$18,637",,,,,FLXN
123,,2018-08-10 12:56:14,2018-08-09,FLXN,Arkowitz David,CFO,P - Purchase,$23.42,4000,44250,+10%,"+$93,680",,,,,FLXN
124,,2018-08-10 09:13:35,2018-08-09,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$22.33,10000,782948,+1%,"+$223,300",,,,,FLXN
125,M,2018-07-03 16:07:23,2018-07-02,FLXN,Bodick Neil,Chief Scientific Officer,S - Sale,$25.07,-50000,451990,-10%,"-$1,253,492",,,,,FLXN
126,D,2018-06-04 16:26:08,2018-06-01,FLXN,Arkowitz David,CFO,A - Grant,$0.00,30000,40250,+293%,+$0,,,,,FLXN
127,D,2018-05-11 16:07:02,2018-05-11,FLXN,Bodick Neil,Chief Scientific Officer,M - OptEx,$0.16,37702,501990,+8%,"+$6,130",,,,,FLXN
128,D,2018-02-02 16:48:43,2018-02-01,FLXN,Wentworth Kerry,Chief Regulatory Officer,A - Grant,$0.00,8333,18307,+84%,+$0,,,,,FLXN
129,D,2018-02-02 16:47:06,2018-02-01,FLXN,Kelley Scott,Chief Medical Officer,A - Grant,$0.00,8333,14892,+127%,+$0,,,,,FLXN
130,D,2018-02-02 16:45:08,2018-02-01,FLXN,Levine Mark S.,GC,A - Grant,$0.00,8333,8333,New,+$0,,,,,FLXN
131,D,2018-02-02 16:41:13,2018-02-01,FLXN,Clayman Michael D.,"Pres, CEO",A - Grant,$0.00,29167,772394,+4%,+$0,,,,,FLXN
132,D,2018-02-02 16:39:04,2018-02-01,FLXN,Bodick Neil,Chief Scientific Officer,A - Grant,$0.00,10000,464288,+2%,+$0,,,,,FLXN
133,,2017-11-22 17:28:50,2017-11-21,FLXN,Bodick Neil,Chief Scientific Officer,P - Purchase,$24.49,2700,454288,+1%,"+$66,112",,,,,FLXN
134,,2017-11-09 09:13:07,2017-11-08,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$23.60,5000,743061,+1%,"+$118,000",,,,,FLXN
135,D,2017-10-10 16:43:07,2017-10-06,FLXN,Bodick Neil,Chief Scientific Officer,F - Tax,$29.93,-1598,451588,0%,"-$47,835",,,,,FLXN
136,D,2017-10-10 16:43:07,2017-10-06,FLXN,Bodick Neil,Chief Scientific Officer,M - OptEx,$0.00,4566,451588,+1%,+$0,,,,,FLXN
137,D,2017-10-10 16:39:56,2017-10-06,FLXN,Clayman Michael D.,"Pres, CEO",F - Tax,$29.93,-5794,738061,-1%,"-$173,443",,,,,FLXN
138,D,2017-10-10 16:39:56,2017-10-06,FLXN,Clayman Michael D.,"Pres, CEO",M - OptEx,$0.00,14800,738061,+2%,+$0,,,,,FLXN
139,DM,2017-09-15 17:12:15,2017-08-31,FLXN,Deniz Yamo,Chief Medical Officer,P - Purchase,$24.48,5375,9000,+148%,"+$131,575",,,,,FLXN
140,,2017-06-20 16:24:31,2017-06-16,FLXN,Stejbach Mark,Dir,P - Purchase,$17.02,1580,1580,New,"+$26,888",,,,,FLXN
141,,2017-06-06 18:49:40,2017-06-05,FLXN,Colella Samuel D,"Dir, 10%",P - Purchase,$17.01,5000,3994929,0%,"+$85,048",,,,,FLXN
142,,2017-06-06 18:47:58,2017-06-05,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$17.23,5000,727812,+1%,"+$86,152",,,,,FLXN
143,AD,2017-05-19 16:34:13,2017-05-15,FLXN,Bodick Neil,Chief Medical Officer,M - OptEx,$2.52,6830,448620,+2%,"+$17,214",,,,,FLXN
144,AD,2017-05-19 16:34:13,2017-05-15,FLXN,Bodick Neil,Chief Medical Officer,S - Sale+OE,$18.95,-6830,448620,-1%,"-$129,448",,,,,FLXN
145,AD,2017-05-19 16:32:48,2017-04-17,FLXN,Bodick Neil,Chief Medical Officer,M - OptEx,$2.52,5000,448620,+1%,"+$12,602",,,,,FLXN
146,AD,2017-05-19 16:32:48,2017-04-17,FLXN,Bodick Neil,Chief Medical Officer,S - Sale+OE,$28.23,-5000,448620,-1%,"-$141,132",,,,,FLXN
147,AD,2017-05-19 16:31:14,2017-03-17,FLXN,Bodick Neil,Chief Medical Officer,M - OptEx,$2.52,5000,448620,+1%,"+$12,602",,,,,FLXN
148,AD,2017-05-19 16:31:14,2017-03-17,FLXN,Bodick Neil,Chief Medical Officer,S - Sale+OE,$20.41,-5000,448620,-1%,"-$102,039",,,,,FLXN
149,AD,2017-05-19 16:28:22,2017-02-24,FLXN,Bodick Neil,Chief Medical Officer,M - OptEx,$2.52,4000,448620,+1%,"+$10,081",,,,,FLXN
150,AD,2017-05-19 16:28:22,2017-02-24,FLXN,Bodick Neil,Chief Medical Officer,S - Sale+OE,$19.15,-5000,448620,-1%,"-$95,758",,,,,FLXN
151,,2017-05-17 16:15:52,2017-05-15,FLXN,Bodick Neil,Chief Medical Officer,S - Sale,$18.95,-6830,427790,-2%,"-$129,448",,,,,FLXN
152,,2017-04-18 19:45:51,2017-04-17,FLXN,Bodick Neil,Chief Medical Officer,S - Sale,$28.23,-5000,434620,-1%,"-$141,132",-2.0,-5.0,,,FLXN
153,D,2017-03-24 16:24:10,2017-03-23,FLXN,Driscoll Frederick W,CFO,M - OptEx,$7.89,3000,7777,+63%,"+$23,658",7.0,-1.0,-4.0,,FLXN
154,D,2017-03-24 16:24:10,2017-03-23,FLXN,Driscoll Frederick W,CFO,S - Sale+OE,$23.00,-3000,7777,-28%,"-$69,000",7.0,-1.0,-4.0,,FLXN
155,,2017-03-20 19:42:11,2017-03-17,FLXN,Bodick Neil,Chief Medical Officer,S - Sale,$20.41,-5000,439620,-1%,"-$102,039",-6.0,32.0,34.0,,FLXN
156,,2017-03-10 17:03:15,2016-06-21,FLXN,Clayman Michael D.,"Pres, CEO",G - Gift,$0.00,-31444,722812,+5%,-$0,0.0,-2.0,27.0,,FLXN
157,D,2017-03-02 16:56:09,2017-02-28,FLXN,Driscoll Frederick W,CFO,M - OptEx,$7.89,30000,7777,-135%,"+$236,583",2.0,-1.0,30.0,,FLXN
158,D,2017-03-02 16:56:09,2017-02-28,FLXN,Driscoll Frederick W,CFO,S - Sale+OE,$19.97,-33434,7777,-81%,"-$667,679",2.0,-1.0,30.0,,FLXN
159,,2017-02-27 16:17:11,2017-02-24,FLXN,Bodick Neil,Chief Medical Officer,S - Sale,$19.15,-5000,444620,-1%,"-$95,758",-3.0,3.0,45.0,,FLXN
160,,2017-01-23 19:10:30,2017-01-20,FLXN,Bodick Neil,Chief Medical Officer,S - Sale,$18.35,-5000,449620,-1%,"-$91,747",-1.0,2.0,4.0,,FLXN
161,,2016-12-22 16:40:18,2016-12-21,FLXN,Bodick Neil,Chief Medical Officer,S - Sale,$18.46,-10000,454620,-2%,"-$184,628",11.0,2.0,1.0,,FLXN
162,,2016-12-05 14:40:51,2016-12-01,FLXN,Colella Samuel D,"Dir, 10%",P - Purchase,$16.38,10000,3989929,0%,"+$163,807",4.0,12.0,11.0,,FLXN
163,,2016-11-23 20:17:20,2016-11-23,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$18.41,1667,722665,0%,"+$30,688",-1.0,-11.0,0.0,,FLXN
164,,2016-11-23 08:35:31,2016-11-22,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$17.95,1666,720998,0%,"+$29,900",3.0,-8.0,3.0,,FLXN
165,,2016-11-22 18:40:11,2016-11-21,FLXN,Colella Samuel D,"Dir, 10%",P - Purchase,$18.00,33333,3979929,+1%,"+$599,994",3.0,-4.0,1.0,,FLXN
166,,2016-11-22 14:28:40,2016-11-21,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$17.90,1666,719332,0%,"+$29,827",1.0,-3.0,1.0,,FLXN
167,M,2016-06-22 13:36:49,2016-06-20,FLXN,Colella Samuel D,"Dir, 10%",P - Purchase,$13.71,25504,3946596,+1%,"+$349,600",0.0,10.0,20.0,39.0,FLXN
168,,2016-06-16 17:59:00,2016-06-14,FLXN,Merrifield C Ann,Dir,P - Purchase,$13.39,1000,2000,+100%,"+$13,387",-5.0,-1.0,12.0,34.0,FLXN
169,,2016-06-10 21:40:32,2016-06-08,FLXN,Lubash Barbara N,10%,P - Purchase,$14.00,714285,409422,-234%,"+$9,999,990",0.0,1.0,14.0,37.0,FLXN
170,,2016-06-10 21:16:18,2016-06-08,FLXN,"Versant Ventures Iii, LLC",10%,P - Purchase,$14.00,714285,409422,-234%,"+$9,999,990",0.0,1.0,14.0,37.0,FLXN
171,,2016-06-10 20:25:17,2016-06-08,FLXN,Colella Samuel D,"Dir, 10%",P - Purchase,$14.00,714285,409422,-234%,"+$9,999,990",0.0,1.0,14.0,37.0,FLXN
172,D,2016-05-24 17:26:11,2016-05-23,FLXN,Clayman Michael D.,"Pres, CEO",M - OptEx,$0.16,10369,717666,+1%,"+$1,686",-1.0,56.0,22.0,63.0,FLXN
173,,2016-05-23 16:04:16,2016-05-20,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$10.41,2000,705512,0%,"+$20,810",9.0,47.0,30.0,71.0,FLXN
174,,2016-05-20 17:52:36,2016-05-19,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$9.65,2000,703512,0%,"+$19,297",1.0,70.0,37.0,79.0,FLXN
175,,2016-05-20 17:51:17,2016-05-19,FLXN,Bodick Neil,Chief Medical Officer,P - Purchase,$10.00,850,464620,0%,"+$8,500",1.0,70.0,37.0,79.0,FLXN
176,,2016-05-19 17:30:26,2016-05-18,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$10.23,2000,701512,0%,"+$20,465",8.0,17.0,35.0,104.0,FLXN
177,,2016-05-19 17:29:00,2016-05-18,FLXN,Bodick Neil,Chief Medical Officer,P - Purchase,$10.20,2100,463770,0%,"+$21,420",8.0,17.0,35.0,104.0,FLXN
178,,2016-05-18 17:23:25,2016-05-17,FLXN,Driscoll Frederick W,CFO,P - Purchase,$9.87,2500,8434,+42%,"+$24,668",-5.0,14.0,38.0,112.0,FLXN
179,,2016-05-18 17:22:36,2016-05-17,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$9.73,2000,699512,0%,"+$19,465",-5.0,14.0,38.0,112.0,FLXN
180,,2016-05-18 17:21:30,2016-05-17,FLXN,Bodick Neil,Chief Medical Officer,P - Purchase,$9.60,800,461670,0%,"+$7,680",-5.0,14.0,38.0,112.0,FLXN
181,,2016-05-17 18:12:09,2016-05-16,FLXN,Driscoll Frederick W,CFO,P - Purchase,$9.19,2500,5934,+73%,"+$22,972",7.0,10.0,43.0,124.0,FLXN
182,,2016-05-17 18:10:50,2016-05-16,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,$9.51,2000,697512,0%,"+$19,025",7.0,10.0,43.0,124.0,FLXN
183,,2016-05-17 18:08:27,2016-05-16,FLXN,Bodick Neil,Chief Medical Officer,P - Purchase,$9.22,1250,460870,0%,"+$11,525",7.0,10.0,43.0,124.0,FLXN
184,,2015-09-14 16:32:30,2015-09-11,FLXN,Merrifield C Ann,Dir,P - Purchase,$23.00,1000,1000,New,"+$23,000",-4.0,2.0,-40.0,-63.0,FLXN
185,M,2015-06-22 18:22:03,2015-06-18,FLXN,Novo A/s,10%,S - Sale,$20.61,-150000,2133131,-7%,"-$3,091,973",2.0,0.0,17.0,-11.0,FLXN
186,D,2015-03-25 16:01:45,2015-03-24,FLXN,Clayman Michael D.,"Pres, CEO",M - OptEx,$0.16,5000,693728,+1%,+$813,0.0,-1.0,-17.0,9.0,FLXN
187,,2015-03-16 17:19:28,2015-03-16,FLXN,Bodick Neil,Chief Medical Officer,S - Sale,$25.28,-4000,459620,-1%,"-$101,115",3.0,8.0,-18.0,-11.0,FLXN
188,,2015-03-11 14:22:01,2015-03-10,FLXN,Bodick Neil,Chief Medical Officer,S - Sale,$24.26,-4000,463620,-1%,"-$97,055",0.0,6.0,-8.0,15.0,FLXN
189,,2015-03-05 20:50:23,2015-03-04,FLXN,Bodick Neil,Chief Medical Officer,S - Sale,$23.45,-4000,467620,-1%,"-$93,790",-5.0,0.0,-9.0,-3.0,FLXN
190,,2015-02-26 20:25:17,2015-02-26,FLXN,Bodick Neil,Chief Medical Officer,S - Sale,$22.44,-4000,471620,-1%,"-$89,766",0.0,11.0,0.0,-1.0,FLXN
191,,2015-01-22 14:02:37,2014-10-29,FLXN,Sofinnova Partners Sas,10%,S - Sale,$20.00,-10000,2095491,0%,"-$200,000",1.0,-5.0,-2.0,12.0,FLXN
192,,2014-12-18 15:44:52,2014-12-17,FLXN,Novo A/s,10%,P - Purchase,$17.00,500000,2283131,+28%,"+$8,500,000",0.0,-2.0,10.0,-3.0,FLXN
193,D,2014-09-12 21:00:12,2014-09-10,FLXN,"Versant Venture Capital Iii, L.P.","Dir, 10%",X - OptEx,$17.61,2250,2250,-50%,"$39,623",-6.0,-8.0,-26.0,31.0,FLXN
194,D,2014-09-12 20:13:05,2014-09-10,FLXN,"Versant Venture Capital Iii, L.P.","Dir, 10%",X - OptEx,$17.61,2250,2250,-50%,"$39,623",-6.0,-8.0,-26.0,31.0,FLXN
195,D,2014-02-20 17:11:27,2014-02-18,FLXN,Novo A/s,"SEE REMARKS, 10%",C - Converted deriv,$0.00,1090823,1783131,-38%,$0,4.0,7.0,31.0,-7.0,FLXN
196,D,2014-02-20 17:11:27,2014-02-18,FLXN,Novo A/s,"SEE REMARKS, 10%",P - Purchase,$13.00,692308,1783131,+63%,"+$9,000,004",4.0,7.0,31.0,-7.0,FLXN
197,D,2014-02-20 15:01:43,2014-02-18,FLXN,"Versant Venture Capital Iii, L.P.",10%,C - Converted deriv,$0.00,2793335,8923017,-24%,$0,0.0,8.0,31.0,-7.0,FLXN
198,D,2014-02-20 15:01:43,2014-02-18,FLXN,"Versant Venture Capital Iii, L.P.",10%,P - Purchase,$13.00,307692,8923017,+4%,"+$3,999,996",0.0,8.0,31.0,-7.0,FLXN
199,D,2014-02-20 15:00:26,2014-02-18,FLXN,Tordjman Rafael,"Dir, 10%",C - Converted deriv,$0.00,1874722,2105491,-47%,$0,0.0,8.0,31.0,-7.0,FLXN
200,D,2014-02-20 15:00:26,2014-02-18,FLXN,Tordjman Rafael,"Dir, 10%",P - Purchase,$13.00,230769,2105491,+12%,"+$2,999,997",0.0,8.0,31.0,-7.0,FLXN
201,D,2014-02-20 14:59:13,2014-02-18,FLXN,Sofinnova Partners Sas,10%,C - Converted deriv,$0.00,1874722,2105491,-47%,$0,0.0,8.0,31.0,-7.0,FLXN
202,D,2014-02-20 14:59:13,2014-02-18,FLXN,Sofinnova Partners Sas,10%,P - Purchase,$13.00,230769,2105491,+12%,"+$2,999,997",0.0,8.0,31.0,-7.0,FLXN
203,D,2014-02-20 14:53:24,2014-02-18,FLXN,Schwab Andrew J.,"Dir, 10%",C - Converted deriv,$0.00,1499777,1512076,-50%,$0,0.0,8.0,31.0,-7.0,FLXN
204,D,2014-02-20 14:51:57,2014-02-18,FLXN,Pfizer Inc,10%,C - Converted deriv,$0.00,1687250,1687250,-50%,$0,0.0,8.0,31.0,-7.0,FLXN
205,D,2014-02-20 14:50:17,2014-02-18,FLXN,Colella Samuel D,"Dir, 10%",C - Converted deriv,$0.00,2793335,3206807,-47%,$0,0.0,8.0,31.0,-7.0,FLXN
206,D,2014-02-20 14:50:17,2014-02-18,FLXN,Colella Samuel D,"Dir, 10%",P - Purchase,$13.00,307692,3206807,+11%,"+$3,999,996",0.0,8.0,31.0,-7.0,FLXN
207,D,2014-02-20 14:47:49,2014-02-18,FLXN,Clayman Michael D.,"Pres, CEO",C - Converted deriv,$0.00,356703,686944,-34%,$0,0.0,8.0,31.0,-7.0,FLXN
208,D,2014-02-20 14:46:10,2014-02-18,FLXN,Bolzon Bradley J Phd,"Dir, 10%",C - Converted deriv,$0.00,2793335,3206807,-47%,$0,0.0,8.0,31.0,-7.0,FLXN
209,D,2014-02-20 14:46:10,2014-02-18,FLXN,Bolzon Bradley J Phd,"Dir, 10%",P - Purchase,$13.00,307692,3206807,+11%,"+$3,999,996",0.0,8.0,31.0,-7.0,FLXN
210,D,2014-02-20 14:44:44,2014-02-18,FLXN,Bodick Neil,Chief Medical Officer,C - Converted deriv,$0.00,356703,475620,-43%,$0,0.0,8.0,31.0,-7.0,FLXN
211,D,2014-02-20 14:43:45,2014-02-18,FLXN,5Am Ventures II LP,10%,C - Converted deriv,$0.00,1499777,1512076,-50%,$0,0.0,8.0,31.0,-7.0,FLXN
